BEAMing up personalized medicine: mutation detection in blood.

Clinical cancer research : an official journal of the American Association for Cancer Research ·第 18 卷 ·第 12 期 ·2012-12-20

Richardson Andrea L, Iglehart J Dirk

摘要

BEAMing is a feasible, accurate, and sensitive method for detection of PIK3CA mutations in circulating tumor DNA in blood. Mutation status of PIK3CA may change between primary tumor and recurrence. The results suggest a new approach for noninvasive determination of current mutation status in patients with metastatic disease.

文献信息

期刊

Clinical cancer research : an official journal of the American Association for Cancer Research

期刊简称

Clin Cancer Res

ISSN

1078-0432

发表日期

2012-12-20

收录日期

2012-06-18

更新日期

2016-10-25

语言

英语

国家/地区

United States

NLM ID

9502500

外部链接

PubMed 原文查看期刊详情

分析服务

BEAMing up personalized medicine: mutation detection in blood.

联系地址

微信公众号